Literature DB >> 31958187

Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score.

Hirotaka Iwaki1,2, Cornelis Blauwendraat1, Mary B Makarious1, Sara Bandrés-Ciga1, Hampton L Leonard1, J Raphael Gibbs1, Dena G Hernandez1, Sonja W Scholz1, Faraz Faghri1, Mike A Nalls1,2, Andrew B Singleton1.   

Abstract

BACKGROUND: Although the leucine-rich repeat kinase 2 p.G2019S mutation has been demonstrated to be a strong risk factor for PD, factors that contribute to penetrance among carriers, other than aging, have not been well identified.
OBJECTIVES: To evaluate whether a cumulative genetic risk identified in the recent genome-wide study is associated with penetrance of PD among p.G2019S mutation carriers.
METHODS: We included p.G2019S heterozygote carriers with European ancestry in three genetic cohorts in which the mutation carriers with and without PD were selectively recruited. We also included the carriers from two data sets: one from a case-control setting without selection of mutation carriers and the other from a population sampling. Associations between polygenic risk score constructed from 89 variants reported recently and PD were tested and meta-analyzed. We also explored the interaction of age and PRS.
RESULTS: After excluding eight homozygotes, 833 p.G2019S heterozygote carriers (439 PD and 394 unaffected) were analyzed. Polygenic risk score was associated with a higher penetrance of PD (odds ratio: 1.34; 95% confidence interval: [1.09, 1.64] per +1 standard deviation; P = 0.005). In addition, associations with polygenic risk score and penetrance were stronger in the younger participants (main effect: odds ratio 1.28 [1.04, 1.58] per +1 standard deviation; P = 0.022; interaction effect: odds ratio 0.78 [0.64, 0.94] per +1 standard deviation and + 10 years of age; P = 0.008).
CONCLUSIONS: Our results suggest that there is a genetic contribution for penetrance of PD among p.G2019S carriers. These results have important etiological consequences and potential impact on the selection of subjects for clinical trials.
© 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  G2019S; LRRK2; Parkinson's disease; genetics; polygenic risk score

Mesh:

Substances:

Year:  2020        PMID: 31958187      PMCID: PMC8975556          DOI: 10.1002/mds.27974

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   9.698


  17 in total

1.  Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.

Authors:  Annie J Lee; Yuanjia Wang; Roy N Alcalay; Helen Mejia-Santana; Rachel Saunders-Pullman; Susan Bressman; Jean-Christophe Corvol; Alexis Brice; Suzanne Lesage; Graziella Mangone; Eduardo Tolosa; Claustre Pont-Sunyer; Dolores Vilas; Birgitt Schüle; Farah Kausar; Tatiana Foroud; Daniela Berg; Kathrin Brockmann; Stefano Goldwurm; Chiara Siri; Rosanna Asselta; Javier Ruiz-Martinez; Elisabet Mondragón; Connie Marras; Taneera Ghate; Nir Giladi; Anat Mirelman; Karen Marder
Journal:  Mov Disord       Date:  2017-06-22       Impact factor: 10.338

2.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Laurie J Ozelius; Geetha Senthil; Rachel Saunders-Pullman; Erin Ohmann; Amanda Deligtisch; Michele Tagliati; Ann L Hunt; Christine Klein; Brian Henick; Susan M Hailpern; Richard B Lipton; Jeannie Soto-Valencia; Neil Risch; Susan B Bressman
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

3.  Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.

Authors:  William C Nichols; Nathan Pankratz; Dena Hernandez; Coro Paisán-Ruíz; Shushant Jain; Cheryl A Halter; Veronika E Michaels; Terry Reed; Alice Rudolph; Clifford W Shults; Andrew Singleton; Tatiana Foroud
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

4.  Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.

Authors:  Cornelis Blauwendraat; Karl Heilbron; Costanza L Vallerga; Sara Bandres-Ciga; Rainer von Coelln; Lasse Pihlstrøm; Javier Simón-Sánchez; Claudia Schulte; Manu Sharma; Lynne Krohn; Ari Siitonen; Hirotaka Iwaki; Hampton Leonard; Alastair J Noyce; Manuela Tan; J Raphael Gibbs; Dena G Hernandez; Sonja W Scholz; Joseph Jankovic; Lisa M Shulman; Suzanne Lesage; Jean-Christophe Corvol; Alexis Brice; Jacobus J van Hilten; Johan Marinus; Johanna Eerola-Rautio; Pentti Tienari; Kari Majamaa; Mathias Toft; Donald G Grosset; Thomas Gasser; Peter Heutink; Joshua M Shulman; Nicolas Wood; John Hardy; Huw R Morris; David A Hinds; Jacob Gratten; Peter M Visscher; Ziv Gan-Or; Mike A Nalls; Andrew B Singleton
Journal:  Mov Disord       Date:  2019-04-07       Impact factor: 10.338

5.  A common LRRK2 mutation in idiopathic Parkinson's disease.

Authors:  William P Gilks; Patrick M Abou-Sleiman; Sonia Gandhi; Shushant Jain; Andrew Singleton; Andrew J Lees; Karen Shaw; Kailash P Bhatia; Vincenzo Bonifati; Niall P Quinn; John Lynch; Daniel G Healy; Janice L Holton; Tamas Revesz; Nicholas W Wood
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

6.  Genetic risk and age in Parkinson's disease: Continuum not stratum.

Authors:  Mike A Nalls; Valentina Escott-Price; Nigel M Williams; Steven Lubbe; Margaux F Keller; Huw R Morris; Andrew B Singleton
Journal:  Mov Disord       Date:  2015-03-17       Impact factor: 10.338

7.  Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson's disease.

Authors:  Mike A Nalls; Ziv Gan-Or; Hampton Leonard; Cornelis Blauwendraat; Lynne Krohn; Faraz Faghri; Hirotaka Iwaki; Glen Ferguson; Aaron G Day-Williams; David J Stone; Andrew B Singleton
Journal:  J Med Genet       Date:  2019-11-29       Impact factor: 6.318

8.  A reference panel of 64,976 haplotypes for genotype imputation.

Authors:  Shane McCarthy; Sayantan Das; Warren Kretzschmar; Olivier Delaneau; Andrew R Wood; Alexander Teumer; Hyun Min Kang; Christian Fuchsberger; Petr Danecek; Kevin Sharp; Yang Luo; Carlo Sidore; Alan Kwong; Nicholas Timpson; Seppo Koskinen; Scott Vrieze; Laura J Scott; He Zhang; Anubha Mahajan; Jan Veldink; Ulrike Peters; Carlos Pato; Cornelia M van Duijn; Christopher E Gillies; Ilaria Gandin; Massimo Mezzavilla; Arthur Gilly; Massimiliano Cocca; Michela Traglia; Andrea Angius; Jeffrey C Barrett; Dorrett Boomsma; Kari Branham; Gerome Breen; Chad M Brummett; Fabio Busonero; Harry Campbell; Andrew Chan; Sai Chen; Emily Chew; Francis S Collins; Laura J Corbin; George Davey Smith; George Dedoussis; Marcus Dorr; Aliki-Eleni Farmaki; Luigi Ferrucci; Lukas Forer; Ross M Fraser; Stacey Gabriel; Shawn Levy; Leif Groop; Tabitha Harrison; Andrew Hattersley; Oddgeir L Holmen; Kristian Hveem; Matthias Kretzler; James C Lee; Matt McGue; Thomas Meitinger; David Melzer; Josine L Min; Karen L Mohlke; John B Vincent; Matthias Nauck; Deborah Nickerson; Aarno Palotie; Michele Pato; Nicola Pirastu; Melvin McInnis; J Brent Richards; Cinzia Sala; Veikko Salomaa; David Schlessinger; Sebastian Schoenherr; P Eline Slagboom; Kerrin Small; Timothy Spector; Dwight Stambolian; Marcus Tuke; Jaakko Tuomilehto; Leonard H Van den Berg; Wouter Van Rheenen; Uwe Volker; Cisca Wijmenga; Daniela Toniolo; Eleftheria Zeggini; Paolo Gasparini; Matthew G Sampson; James F Wilson; Timothy Frayling; Paul I W de Bakker; Morris A Swertz; Steven McCarroll; Charles Kooperberg; Annelot Dekker; David Altshuler; Cristen Willer; William Iacono; Samuli Ripatti; Nicole Soranzo; Klaudia Walter; Anand Swaroop; Francesco Cucca; Carl A Anderson; Richard M Myers; Michael Boehnke; Mark I McCarthy; Richard Durbin
Journal:  Nat Genet       Date:  2016-08-22       Impact factor: 38.330

9.  The UK Biobank resource with deep phenotyping and genomic data.

Authors:  Clare Bycroft; Colin Freeman; Desislava Petkova; Gavin Band; Lloyd T Elliott; Kevin Sharp; Allan Motyer; Damjan Vukcevic; Olivier Delaneau; Jared O'Connell; Adrian Cortes; Samantha Welsh; Alan Young; Mark Effingham; Gil McVean; Stephen Leslie; Naomi Allen; Peter Donnelly; Jonathan Marchini
Journal:  Nature       Date:  2018-10-10       Impact factor: 49.962

10.  Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.

Authors:  Cornelis Blauwendraat; Xylena Reed; Lynne Krohn; Karl Heilbron; Sara Bandres-Ciga; Manuela Tan; J Raphael Gibbs; Dena G Hernandez; Ravindran Kumaran; Rebekah Langston; Luis Bonet-Ponce; Roy N Alcalay; Sharon Hassin-Baer; Lior Greenbaum; Hirotaka Iwaki; Hampton L Leonard; Francis P Grenn; Jennifer A Ruskey; Marya Sabir; Sarah Ahmed; Mary B Makarious; Lasse Pihlstrøm; Mathias Toft; Jacobus J van Hilten; Johan Marinus; Claudia Schulte; Kathrin Brockmann; Manu Sharma; Ari Siitonen; Kari Majamaa; Johanna Eerola-Rautio; Pentti J Tienari; Alexander Pantelyat; Argye E Hillis; Ted M Dawson; Liana S Rosenthal; Marilyn S Albert; Susan M Resnick; Luigi Ferrucci; Christopher M Morris; Olga Pletnikova; Juan Troncoso; Donald Grosset; Suzanne Lesage; Jean-Christophe Corvol; Alexis Brice; Alastair J Noyce; Eliezer Masliah; Nick Wood; John Hardy; Lisa M Shulman; Joseph Jankovic; Joshua M Shulman; Peter Heutink; Thomas Gasser; Paul Cannon; Sonja W Scholz; Huw Morris; Mark R Cookson; Mike A Nalls; Ziv Gan-Or; Andrew B Singleton
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

View more
  10 in total

1.  Prediction of Parkinson's Disease Risk Based on Genetic Profile and Established Risk Factors.

Authors:  Paraskevi P Chairta; Andreas Hadjisavvas; Andrea N Georgiou; Maria A Loizidou; Kristia Yiangou; Christiana A Demetriou; Yiolanda P Christou; Marios Pantziaris; Kyriaki Michailidou; Eleni Zamba-Papanicolaou
Journal:  Genes (Basel)       Date:  2021-08-20       Impact factor: 4.096

2.  GP2: The Global Parkinson's Genetics Program.

Authors: 
Journal:  Mov Disord       Date:  2021-01-29       Impact factor: 9.698

3.  Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next Steps.

Authors: 
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

4.  Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.

Authors:  Roberto A Ortega; Cuiling Wang; Deborah Raymond; Nicole Bryant; Clemens R Scherzer; Avner Thaler; Roy N Alcalay; Andrew B West; Anat Mirelman; Yuliya Kuras; Karen S Marder; Nir Giladi; Laurie J Ozelius; Susan B Bressman; Rachel Saunders-Pullman
Journal:  JAMA Netw Open       Date:  2021-04-01

5.  Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.

Authors:  Hirotaka Iwaki; Hampton L Leonard; Mary B Makarious; Matt Bookman; Barry Landin; David Vismer; Bradford Casey; J Raphael Gibbs; Dena G Hernandez; Cornelis Blauwendraat; Daniel Vitale; Yeajin Song; Dinesh Kumar; Clifton L Dalgard; Mahdiar Sadeghi; Xianjun Dong; Leonie Misquitta; Sonja W Scholz; Clemens R Scherzer; Mike A Nalls; Shameek Biswas; Andrew B Singleton
Journal:  Mov Disord       Date:  2021-05-07       Impact factor: 9.698

6.  Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors.

Authors:  Hui Liu; Mohammad Dehestani; Cornelis Blauwendraat; Mary B Makarious; Hampton Leonard; Jonggeol J Kim; Claudia Schulte; Alastair Noyce; Benjamin M Jacobs; Isabelle Foote; Manu Sharma; Mike Nalls; Andrew Singleton; Thomas Gasser; Sara Bandres-Ciga
Journal:  Ann Neurol       Date:  2022-06-24       Impact factor: 11.274

Review 7.  Missing heritability in Parkinson's disease: the emerging role of non-coding genetic variation.

Authors:  Jochen Ohnmacht; Patrick May; Lasse Sinkkonen; Rejko Krüger
Journal:  J Neural Transm (Vienna)       Date:  2020-04-04       Impact factor: 3.575

Review 8.  Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.

Authors:  Seung Hyun Lee; Sang-Min Park; Sang Seok Yeo; Ojin Kwon; Mi-Kyung Lee; Horyong Yoo; Eun Kyoung Ahn; Jae Young Jang; Jung-Hee Jang
Journal:  Diagnostics (Basel)       Date:  2022-01-04

Review 9.  Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.

Authors:  Fangzhi Jia; Avi Fellner; Kishore Raj Kumar
Journal:  Genes (Basel)       Date:  2022-03-07       Impact factor: 4.096

10.  The Parkinson's Disease Genome-Wide Association Study Locus Browser.

Authors:  Francis P Grenn; Jonggeol J Kim; Mary B Makarious; Hirotaka Iwaki; Anastasia Illarionova; Kajsa Brolin; Jillian H Kluss; Artur F Schumacher-Schuh; Hampton Leonard; Faraz Faghri; Kimberley Billingsley; Lynne Krohn; Ashley Hall; Monica Diez-Fairen; Maria Teresa Periñán; Jia Nee Foo; Cynthia Sandor; Caleb Webber; Brian K Fiske; J Raphael Gibbs; Mike A Nalls; Andrew B Singleton; Sara Bandres-Ciga; Xylena Reed; Cornelis Blauwendraat
Journal:  Mov Disord       Date:  2020-08-31       Impact factor: 9.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.